VIGNERI, PAOLO
VIGNERI, PAOLO
MEDICINA CLINICA E SPERIMENTALE
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas
2022-01-01 Failla, M.; Caltabiano, R.; Longo, A.; Russo, A.; Reibaldi, M.; Avitabile, T.; Piombino, E.; Colarossi, C.; Colarossi, L.; Tirro, E.; Vigneri, P.; Foti, P. V.; Broggi, G.
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
2022-01-01 Tirro, E.; Massimino, M.; Broggi, G.; Romano, C.; Minasi, S.; Gianno, F.; Antonelli, M.; Motta, G.; Certo, F.; Altieri, R.; Manzella, L.; Caltabiano, R.; Barbagallo, G. M. V.; Buttarelli, F. R.; Magro, G.; Giangaspero, F.; Vigneri, P.
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors
2021-01-01 Pavone, G.; Motta, L.; Martorana, F.; Motta, G.; Vigneri, P.
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line
2017-01-01 Castagnetti, F; DI RAIMONDO, Francesco; De Vivo, A; Spitaleri, A; Gugliotta, G; Fabbiano, F; Capodanno, I; Mannina, D; Salvucci, M; Antolino, A; Marasca, R; Musso, M; Crugnola, M; Impera, S; Trabacchi, E; Musolino, C; Cavazzini, F; Mineo, G; Tosi, P; Tomaselli, C; Rizzo, M; Siragusa, S; Fogli, M; Ragionieri, R; Zironi, A; Soverini, S; Martinelli, G; Cavo, M; Vigneri, Paolo; Stagno, F; Rosti, G; Baccarani, M.
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy
2024-01-01 Gebbia, V.; Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scollo, P.
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine
2024-01-01 Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scibilia, G.; Scollo, P.; Gebbia, V.
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
2024-01-01 Martorana, F.; Sano, M. V.; Valerio, M. R.; Fogli, S.; Vigneri, P.; Danesi, R.; Gebbia, V.
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor
2020-01-01 Gebbia, Vittorio; Valerio, Maria Rosaria; Firenze, Alberto; Vigneri, Paolo
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment
2019-01-01 Manzella, L.; Massimino, M.; Stella, S.; Tirro, E.; Pennisi, M. S.; Martorana, F.; Motta, G.; Vitale, S. R.; Puma, A.; Romano, C.; Di Gregorio, S.; Russo, M.; Malandrino, P.; Vigneri, P.
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports
2023-01-01 Pennisi, Maria Stella; Di Gregorio, Sandra; Tirrò, Elena; Romano, Chiara; Duminuco, Andrea; Garibaldi, Bruno; Giuffrida, Gaetano; Manzella, Livia; Vigneri, Paolo; Palumbo, Giuseppe A
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
2021-01-01 Di Franco, S.; Bianca, P.; Sardina, D. S.; Turdo, A.; Gaggianesi, M.; Veschi, V.; Nicotra, A.; Mangiapane, L. R.; Lo Iacono, M.; Pillitteri, I.; van Hooff, S.; Martorana, F.; Motta, G.; Gulotta, E.; Lentini, V. L.; Martorana, E.; Fiori, M. E.; Vieni, S.; Bongiorno, M. R.; Giannone, G.; Giuffrida, D.; Memeo, L.; Colarossi, L.; Mare, M.; Vigneri, P.; Todaro, M.; De Maria, R.; Medema, J. P.; Stassi, G.
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
1996-01-01 Bongarzone, I; Fugazzola, L; Vigneri, Paolo; Mariani, L; Mondellini, P; Pacini, F; Basolo, F; Pinchera, A; Pilotti, S; Pierotti, Ma
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
2021-01-01 Martorana, F.; Motta, G.; Pavone, G.; Motta, L.; Stella, S.; Vitale, S. R.; Manzella, L.; Vigneri, P.
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res
2006-01-01 Tirro, E; Consoli, Ml; Massimino, M; Manzella, L; Frasca, F; Sciacca, L; Vicari, L; Stassi, G; Messina, L.; Messina, A; Vigneri, P
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE
file da validare2008-01-01 Vigneri, Paolo; Stagno, F.; Massimino, M.; Berretta, S.; Stella, S.; DEL FABRO, V.; Messina, A.; DI RAIMONDO, Francesco
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA
2019-01-01 Vitale, Silvia R; Sieuwerts, Anieta M; Beije, Nick; Kraan, Jaco; Angus, Lindsay; Mostert, Bianca; Reijm, Esther A; Van, Ngoc M; van Marion, Ronald; Dirix, Luc Y; Hamberg, Paul; de Jongh, Felix E; Jager, Agnes; Foekens, John A; Vigneri, Paolo; Sleijfer, Stefan; Jansen, Maurice P H M; Martens, John W M
Anaplastic thyroid cancer in sicily: The role of environmental characteristics.
2017-01-01 Tavarelli, Martina; Malandrino, Pasqualino; Vigneri, Paolo; Richiusa, Pierina; Maniglia, Adele; Violi, Maria A.; Sapuppo, Giulia; Vella, Veronica; Dardanoni, Gabriella; Vigneri, Riccardo; Pellegriti, Gabriella; Vella, Veronica
Basal insulin and cardiovascular and other outcomes
2012-01-01 Vigneri, R; Vigneri, Paolo; Frittitta, Lucia
BCR-ABL modifies the expression and function of the IRF-5 transcription factor
file da validare2007-01-01 Vigneri, Paolo
BCR-ABL nuclear entrapment by the combination of imatinib mesylate and leptomycin B kilss CML cells: ex vivo study on 35 patients
file da validare2004-01-01 Vigneri, Paolo; Aloisi, A; Digregorio, S; Stagno, F; Guglielmo, P; Sormani, Mp; Bruzzi, P; Giustolisi, R; Messina, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas | 1-gen-2022 | Failla, M.; Caltabiano, R.; Longo, A.; Russo, A.; Reibaldi, M.; Avitabile, T.; Piombino, E.; Colarossi, C.; Colarossi, L.; Tirro, E.; Vigneri, P.; Foti, P. V.; Broggi, G. | |
| A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications | 1-gen-2022 | Tirro, E.; Massimino, M.; Broggi, G.; Romano, C.; Minasi, S.; Gianno, F.; Antonelli, M.; Motta, G.; Certo, F.; Altieri, R.; Manzella, L.; Caltabiano, R.; Barbagallo, G. M. V.; Buttarelli, F. R.; Magro, G.; Giangaspero, F.; Vigneri, P. | |
| A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors | 1-gen-2021 | Pavone, G.; Motta, L.; Martorana, F.; Motta, G.; Vigneri, P. | |
| A population-based study of chronic myeloid leukemia patients treated with imatinib in first line | 1-gen-2017 | Castagnetti, F; DI RAIMONDO, Francesco; De Vivo, A; Spitaleri, A; Gugliotta, G; Fabbiano, F; Capodanno, I; Mannina, D; Salvucci, M; Antolino, A; Marasca, R; Musso, M; Crugnola, M; Impera, S; Trabacchi, E; Musolino, C; Cavazzini, F; Mineo, G; Tosi, P; Tomaselli, C; Rizzo, M; Siragusa, S; Fogli, M; Ragionieri, R; Zironi, A; Soverini, S; Martinelli, G; Cavo, M; Vigneri, Paolo; Stagno, F; Rosti, G; Baccarani, M. | |
| A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy | 1-gen-2024 | Gebbia, V.; Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scollo, P. | |
| A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine | 1-gen-2024 | Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scibilia, G.; Scollo, P.; Gebbia, V. | |
| Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review | 1-gen-2024 | Martorana, F.; Sano, M. V.; Valerio, M. R.; Fogli, S.; Vigneri, P.; Danesi, R.; Gebbia, V. | |
| Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor | 1-gen-2020 | Gebbia, Vittorio; Valerio, Maria Rosaria; Firenze, Alberto; Vigneri, Paolo | |
| Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment | 1-gen-2019 | Manzella, L.; Massimino, M.; Stella, S.; Tirro, E.; Pennisi, M. S.; Martorana, F.; Motta, G.; Vitale, S. R.; Puma, A.; Romano, C.; Di Gregorio, S.; Russo, M.; Malandrino, P.; Vigneri, P. | |
| Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports | 1-gen-2023 | Pennisi, Maria Stella; Di Gregorio, Sandra; Tirrò, Elena; Romano, Chiara; Duminuco, Andrea; Garibaldi, Bruno; Giuffrida, Gaetano; Manzella, Livia; Vigneri, Paolo; Palumbo, Giuseppe A | |
| Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery | 1-gen-2021 | Di Franco, S.; Bianca, P.; Sardina, D. S.; Turdo, A.; Gaggianesi, M.; Veschi, V.; Nicotra, A.; Mangiapane, L. R.; Lo Iacono, M.; Pillitteri, I.; van Hooff, S.; Martorana, F.; Motta, G.; Gulotta, E.; Lentini, V. L.; Martorana, E.; Fiori, M. E.; Vieni, S.; Bongiorno, M. R.; Giannone, G.; Giuffrida, D.; Memeo, L.; Colarossi, L.; Mare, M.; Vigneri, P.; Todaro, M.; De Maria, R.; Medema, J. P.; Stassi, G. | |
| Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma | 1-gen-1996 | Bongarzone, I; Fugazzola, L; Vigneri, Paolo; Mariani, L; Mondellini, P; Pacini, F; Basolo, F; Pinchera, A; Pilotti, S; Pierotti, Ma | |
| AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? | 1-gen-2021 | Martorana, F.; Motta, G.; Pavone, G.; Motta, L.; Stella, S.; Vitale, S. R.; Manzella, L.; Vigneri, P. | |
| Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res | 1-gen-2006 | Tirro, E; Consoli, Ml; Massimino, M; Manzella, L; Frasca, F; Sciacca, L; Vicari, L; Stassi, G; Messina, L.; Messina, A; Vigneri, P | |
| AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE | 1-gen-2008 | Vigneri, Paolo; Stagno, F.; Massimino, M.; Berretta, S.; Stella, S.; DEL FABRO, V.; Messina, A.; DI RAIMONDO, Francesco | file da validare |
| An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA | 1-gen-2019 | Vitale, Silvia R; Sieuwerts, Anieta M; Beije, Nick; Kraan, Jaco; Angus, Lindsay; Mostert, Bianca; Reijm, Esther A; Van, Ngoc M; van Marion, Ronald; Dirix, Luc Y; Hamberg, Paul; de Jongh, Felix E; Jager, Agnes; Foekens, John A; Vigneri, Paolo; Sleijfer, Stefan; Jansen, Maurice P H M; Martens, John W M | |
| Anaplastic thyroid cancer in sicily: The role of environmental characteristics. | 1-gen-2017 | Tavarelli, Martina; Malandrino, Pasqualino; Vigneri, Paolo; Richiusa, Pierina; Maniglia, Adele; Violi, Maria A.; Sapuppo, Giulia; Vella, Veronica; Dardanoni, Gabriella; Vigneri, Riccardo; Pellegriti, Gabriella; Vella, Veronica | |
| Basal insulin and cardiovascular and other outcomes | 1-gen-2012 | Vigneri, R; Vigneri, Paolo; Frittitta, Lucia | |
| BCR-ABL modifies the expression and function of the IRF-5 transcription factor | 1-gen-2007 | Vigneri, Paolo | file da validare |
| BCR-ABL nuclear entrapment by the combination of imatinib mesylate and leptomycin B kilss CML cells: ex vivo study on 35 patients | 1-gen-2004 | Vigneri, Paolo; Aloisi, A; Digregorio, S; Stagno, F; Guglielmo, P; Sormani, Mp; Bruzzi, P; Giustolisi, R; Messina, A. | file da validare |